MHC-I molecules are not essential for cell survival, so cancers can evade immune control by downregulation of MHC-I antigen presentation mechanisms, also frustrating immunotherapies based on re-stimulating anti-tumor CD8+ T cells, such as checkpoint blockade [192]. This evidence concerns the gene CD8A and neoplasm.